How should cardioversion be performed in a patient with significant subcutaneous emphysema?

Cardioversion in Subcutaneous Emphysema: Proceed with Standard Technique

Perform cardioversion using standard pad placement and technique in patients with subcutaneous emphysema—the presence of subcutaneous air does not contraindicate or require modification of cardioversion procedures.

Key Clinical Approach

The provided guidelines address cardioversion extensively but make no mention of subcutaneous emphysema as a contraindication or requiring special consideration 1, 2, 3. This absence is clinically significant: if subcutaneous emphysema posed a meaningful barrier to electrical cardioversion, major international guidelines would address it.

Standard Cardioversion Protocol Applies

For hemodynamically unstable patients:

• Perform immediate cardioversion without delay 1, 3
• Initiate therapeutic anticoagulation (unfractionated heparin or LMWH) concurrently if possible, but do not delay the procedure 2
• Continue anticoagulation for at least 4 weeks post-cardioversion regardless of baseline stroke risk 2

For stable patients with AF >48 hours or unknown duration:

• Provide therapeutic anticoagulation for 3 weeks pre-cardioversion 2, 3
• Alternative: TEE-guided approach with abbreviated anticoagulation if no thrombus identified 2, 3
• Continue anticoagulation for at least 4 weeks post-cardioversion 2, 3

Technical Considerations with Subcutaneous Emphysema

Pad Placement

• Use standard anterolateral or anteroposterior positions 4
• Ensure electrode pads 8-12 cm diameter for optimal transthoracic impedance 4
• Apply firm pressure to ensure full skin contact—this is the only modification needed with subcutaneous emphysema

Potential Impact on Impedance

While subcutaneous air theoretically increases transthoracic impedance, this is not clinically significant enough to prevent successful cardioversion. The research evidence shows subcutaneous emphysema is managed as a separate clinical entity 5, 6, 7, 8 but never mentions it as interfering with defibrillation or cardioversion.

Critical Pitfalls to Avoid

1. Do not delay emergent cardioversion to address subcutaneous emphysema first—hemodynamic instability takes precedence 1, 3

2. Do not use excessive energy initially thinking you need to "overcome" the air—start with standard biphasic energy levels (120-200J depending on device)

3. Do not place pads directly over areas of massive subcutaneous emphysema if alternative positioning achieves better skin contact, but standard positions remain preferred

4. Do not forget anticoagulation protocols—the subcutaneous emphysema does not modify thromboembolic risk management 2, 3

When Subcutaneous Emphysema Becomes Relevant

The subcutaneous emphysema itself may require management if severe (Grade V) 6, 8, but this is separate from the cardioversion decision. If the patient has:

• Airway compromise from cervical emphysema
• Hemodynamic instability from tension pneumothorax
• Respiratory failure

Address these life-threats first with appropriate interventions (needle decompression, chest tube, airway management) 5, then proceed with cardioversion using standard technique.

Bottom Line Algorithm

1. Assess hemodynamic stability → If unstable, cardiovert immediately
2. Apply standard cardioversion pads with firm pressure for good contact
3. Use standard energy protocols (biphasic 120-200J initial)
4. Follow guideline-based anticoagulation regardless of emphysema presence
5. Manage subcutaneous emphysema separately if causing respiratory compromise

The subcutaneous emphysema is a clinical distraction from standard cardioversion protocols—treat the arrhythmia according to established guidelines 1, 2, 3.